urse-led medication monitoring and adverse events

Completed

• Conditions: Other respiratory disorders; Chronic respiratory disease; Respiratory

• Registration Number: ISRCTN10386209
• Lead Sponsor: Swansea University (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2011-04-05
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

1. Patients attending the outpatient respiratory clinics in Singleton Hospital, Swansea, Wales
2. Existing chronic respiratory condition
3. Currently prescribed and receiving at least one of:
3.1. Bronchodilators
3.2. Corticosteroids
3.3. Theophylline
3.4. Leukotriene receptor antagonists

Exclusion Criteria

1. Aged 16 or under
2. Lack of fluency in English or Welsh
3. Patients will be screened by trained physicians and/or nurses to ensure they are well enough to participate in this project, and will be excluded as necessary by their clinicians:
3.1. Patients considered lacking the capacity to consent
3.2. Patients experiencing undue stress or vulnerability

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umber of problems detected in rounds one and two identified using the WWADR profile

Secondary Outcome Measures

Name	Time	Method
1. Number of problems actioned by the nurse in rounds one and two<br>2. Action taken is recorded descriptively and identified using the WWADR profile